Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Envista Holdings Corp (NVST)
USD25.73
-0.49 (-1.87%)
US NYSE Healthcare Medical - Equipment & Services
Address
200 S Kraemer Blvd Bldg E 92821-6208
Brea, CA, US
Brea, CA, US
CEO
Paul A. Keel
Website
envistaco.com
IPO
2019-09-18
CIK 1757073 ISIN US29415F1049
Also trades on
Deutsche Börse · 0HV.DE (EUR)
New York Stock Exchange · NVST (USD)
Description
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
News Sentiment (7d)
Based on only 2 articles — low confidence
- Envista Schedules Second Quarter 2026 Earnings Call PRNewsWire
- Does NVST Stock Still Deserve a Place in Your Portfolio? Zacks Investment Research
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| Danaher Corporation | DHR | 2019-11-15 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD25.73
-0.49 (-1.87%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
3M
Beta
0.89
Float Shares
163.17M
Free Float %
100.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.33% | -17.25% | -8.00% | -15.61% | +20.68% | +11.84% | +30.89% | -26.54% | -44.84% | -13.13% | -13.13% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (19 ratings, all time)
Hold
Price Targets & DCF
Current price
25.73
Low
19.00
-26.2%
Consensus
27.44
+6.6%
Median
25.00
-2.8%
High
35.00
+36.0%
DCF (Unlevered)
49.23
+91.3%
DCF (Levered)
37.22
+44.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
47% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 6 | 0 |
| Hold | 8 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
30.00
+16.6%
|
| Last Quarter | 1 |
30.00
+16.6%
|
| Last Year | 17 |
26.00
+1.0%
|
| All Time | 36 |
25.69
-0.2%
|
Quality scores
Altman Z-Score
1.74
Distress
Piotroski F-Score
8 / 9
Strong
MOAT Score
5 / 10
Developing
Composite Rating
B-
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
2 / 5
Medium
ROA Score
3 / 5
Medium
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Equipment & Services: +14.1%+8.3% Q2'26: +14.4% (vs Q1'25)
-
EPS growth Medical - Equipment & Services: +15.4%+104.3% ★ Q2'26: +130.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Equipment & Services: -3.5%+5.1% Q2'26: -2.2% (vs Q1'25)
-
EBIT margin Medical - Equipment & Services: +1.1%+8.3% ★ Q2'26: +8.9% (vs Q1'25)
-
ROIC Medical - Equipment & Services: +2.4%+3.8% ★ Q2'26: +5.2% (vs Q1'25)
-
Share dilution Medical - Equipment & Services: -2.1%-1.7% ★ Q2'26: -4.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Equipment & Services: 0.31×5.00× Q2'26: 6.36× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 11 Rev. Ana. 10 EPS Ana. |
Dec 2027 11 Rev. Ana. 10 EPS Ana. |
Dec 2028 10 Rev. Ana. 4 EPS Ana. |
Dec 2029 5 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.28B
est: 2.76B (-17.3%)
|
1.93B
est: 2.22B (-13.0%)
|
2.51B
est: 2.49B (+0.7%)
|
2.57B
est: 2.57B (+0.0%)
|
2.57B
est: 2.53B (+1.3%)
|
2.51B
est: 2.50B (+0.3%)
|
2.72B
est: 2.64B (+2.8%)
|
2.86B
2.84B – 2.88B
+8.2% YoY
|
2.96B
2.94B – 3.01B
+3.5% YoY
|
3.07B
3.07B – 3.07B
+3.6% YoY
|
3.17B
3.14B – 3.22B
+3.4% YoY
|
| EBITDA |
377.00M
est: 452.17M (-16.6%)
|
260.20M
est: 362.78M (-28.3%)
|
496.00M
est: 470.62M (+5.4%)
|
497.70M
est: 459.64M (+8.3%)
|
463.00M
est: 409.83M (+13.0%)
|
279.50M
est: 405.06M (-31.0%)
|
341.70M
est: 427.80M (-20.1%)
|
462.79M
459.55M – 466.02M
+8.2% YoY
|
478.78M
475.54M – 486.90M
+3.5% YoY
|
496.20M
496.20M – 496.20M
+3.6% YoY
|
513.27M
508.43M – 520.27M
+3.4% YoY
|
| EBIT |
248.50M
est: 300.99M (-17.4%)
|
127.60M
est: 241.49M (-47.2%)
|
372.40M
est: 295.11M (+26.2%)
|
359.90M
est: 272.14M (+32.2%)
|
327.40M
est: 284.46M (+15.1%)
|
156.40M
est: 281.15M (-44.4%)
|
225.70M
est: 296.93M (-24.0%)
|
321.21M
318.97M – 323.46M
+8.2% YoY
|
332.32M
330.06M – 337.95M
+3.5% YoY
|
344.40M
344.40M – 344.40M
+3.6% YoY
|
356.25M
352.89M – 361.11M
+3.4% YoY
|
| Net Income |
217.60M
est: 298.53M (-27.1%)
|
33.30M
est: 142.78M (-76.7%)
|
340.50M
est: 288.04M (+18.2%)
|
243.10M
est: 277.43M (-12.4%)
|
-100.20M
est: -1.32B (+92.4%)
|
-1.12B
est: 121.79M (-1,018.5%)
|
47.00M
est: 194.59M (-75.8%)
|
240.18M
235.10M – 245.25M
+23.4% YoY
|
267.24M
258.73M – 275.75M
+11.3% YoY
|
270.92M
202.92M – 338.93M
+1.4% YoY
|
322.33M
318.37M – 328.03M
+19.0% YoY
|
| SGA |
970.10M
est: 1.16B (-16.2%)
|
858.80M
est: 928.40M (-7.5%)
|
989.50M
est: 938.40M (+5.4%)
|
1.03B
est: 1.02B (+0.8%)
|
1.03B
est: 1.05B (-2.0%)
|
1.14B
est: 1.04B (+9.4%)
|
1.16B
est: 1.10B (+5.5%)
|
1.19B
1.18B – 1.19B
+8.2% YoY
|
1.23B
1.22B – 1.25B
+3.5% YoY
|
1.27B
1.27B – 1.27B
+3.6% YoY
|
1.32B
1.30B – 1.33B
+3.4% YoY
|
| EPS |
1.35
est: 1.73 (-22.1%)
|
0.27
est: 0.83 (-67.4%)
|
1.63
est: 1.82 (-10.4%)
|
1.46
est: 1.91 (-23.5%)
|
-0.60
est: -7.74 (+92.3%)
|
-6.50
est: 0.71 (-1,009.3%)
|
0.28
est: 1.15 (-75.5%)
|
1.43
1.39 – 1.45
+24.8% YoY
|
1.57
1.53 – 1.63
+9.8% YoY
|
1.72
1.20 – 2.00
+9.3% YoY
|
1.91
1.88 – 1.94
+11.0% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-24 | Morgan Stanley | Equal Weight | Equal Weight | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | B- | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | B- | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | B- | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | B- | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | B- | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-01 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-15 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
274.29M
OE per share TTM
1.63
Owner's Yield
6.18%
Maintenance CapEx ratio
8.41%
Maint CapEx / Avg PPE
17.8%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
107
Total invested
182.79M
Insider transactions (90d)
0
Beneficial owners (>5%)
11
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Eaton Vance Management 04-3101341 | 15.62M | 11.00% | 15.62M | — | 15.62M | — | IA | — | 2021-02-12 | ↗ |
| 2 | Morgan Stanley | 13.48M | 8.30% | — | 13.03M | — | 13.44M | HC, CO | — | 2023-02-09 | ↗ |
| 3 | Lazard Asset Management LLC | 12.03M | 11.00% | 7.84M | — | 12.03M | — | IA | Delaware | 2023-03-09 | ↗ |
| 4 | (1) BlackRock, Inc. | 11.74M | 7.40% | 11.20M | — | 11.74M | — | HC | Delaware | 2021-02-05 | ↗ |
| 5 | Atlanta Capital Management Company, LLC | 10.53M | 6.50% | — | 10.24M | — | 10.53M | IA | — | 2023-02-09 | ↗ |
| 6 | 04-2747644 | 9.88M | 6.10% | 9.41M | — | 9.88M | — | IA | Delaware | 2023-02-08 | ↗ |
| 7 | The Vanguard Group - 23-1945930 | 9.75M | 6.14% | 78.2K | 22.3K | 9.67M | 85.4K | IA | Pennsylvania | 2020-02-11 | ↗ |
| 8 | Eaton Vance Atlanta Capital SMID-Cap Fund | 8.10M | 4.97% | — | 8.10M | — | 8.10M | IV | — | 2023-02-09 | ↗ |
| 9 | 2. | 3.28M | 12.00% | 2.09M | — | 3.28M | — | IA | US | 2022-02-11 | ↗ |
| 10 | 52-0556948 | 170.5K | 0.10% | 132.0K | — | 170.5K | — | IA | Maryland | 2022-02-14 | ↗ |
| 11 | Boston Management and Research | 89.2K | 0.10% | — | 89.2K | — | 89.2K | IA | — | 2023-02-09 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
107
-229 vs prev Q
New positions
19
Closed positions
245
Increased
55
Reduced
28
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 17.54M -2.1M (-10.6%) | 380.78M -18.8M (-4.7%) | 10.44% -1.168 pp | 0.01% -0.001 pp | USD19.67 +10.4% | 6 qtrs — |
| 2 | VANGUARD GROUP INC | 16.10M -287.2K (-1.8%) | 349.45M +15.7M (+4.7%) | 9.58% -0.113 pp | 0.01% +0.000 pp | USD28.13 -22.8% | 26 qtrs — |
| 3 | ARIEL INVESTMENTS, LLC | 11.97M -33.7K (-0.3%) | 259.88M +15.4M (+6.3%) | 7.28% +0.178 pp | 2.81% +0.192 pp | USD20.43 +6.3% | 24 qtrs — |
| 4 | DIMENSIONAL FUND ADVISORS LP | 9.63M +90.6K (+0.9%) | 209.04M +14.8M (+7.6%) | 5.73% +0.088 pp | 0.04% +0.002 pp | USD25.84 -16.0% | 25 qtrs — |
| 5 | MORGAN STANLEY | 8.81M -1.2M (-12.0%) | 191.25M -12.7M (-6.2%) | 5.24% -0.681 pp | 0.01% -0.001 pp | USD32.22 -32.6% | 26 qtrs — |
| 6 | FRANKLIN RESOURCES INC | 8.07M -684.5K (-7.8%) | 175.15M -3.1M (-1.8%) | 4.80% -0.377 pp | 0.04% -0.002 pp | USD21.90 -0.9% | 25 qtrs — |
| 7 | VICTORY CAPITAL MANAGEMENT INC | 6.06M +146.7K (+2.5%) | 131.47M +11.1M (+9.2%) | 3.68% +0.187 pp | 0.07% +0.004 pp | USD18.38 +18.1% | 25 qtrs — |
| 8 | ALLIANCEBERNSTEIN L.P. | 6.04M -63.0K (-1.0%) | 131.04M +6.8M (+5.5%) | 3.67% +0.063 pp | 0.04% +0.002 pp | USD18.72 +16.0% | 25 qtrs — |
| 9 | GATES CAPITAL MANAGEMENT, INC. | 5.81M -414.9K (-6.7%) | 126.09M -667.7K (-0.5%) | 3.53% -0.149 pp | 3.32% +1.052 pp | USD21.66 +0.2% | 18 qtrs — |
| 10 | STATE STREET CORP | 5.20M -113.9K (-2.1%) | 112.79M +4.6M (+4.3%) | 3.09% -0.049 pp | 0.00% +0.000 pp | USD32.44 -33.1% | 25 qtrs — |
| 11 | HARRIS ASSOCIATES L P | 4.65M -2.2M (-32.2%) | 100.86M -38.7M (-27.7%) | 2.83% -1.227 pp | 0.13% -0.096 pp | USD29.91 -27.4% | 24 qtrs — |
| 12 | AMERICAN CENTURY COMPANIES INC | 4.59M -657.1K (-12.5%) | 99.63M -7.2M (-6.8%) | 2.79% -0.313 pp | 0.05% -0.004 pp | USD28.28 -23.2% | 24 qtrs — |
| 13 | CLARKSTON CAPITAL PARTNERS, LLC | 4.21M -105.5K (-2.4%) | 91.44M +3.5M (+4.0%) | 2.56% +0.007 pp | 2.12% +0.223 pp | USD19.68 +10.3% | 8 qtrs — |
| 14 | FULLER & THALER ASSET MANAGEMENT, INC. | 3.88M -368.6K (-8.7%) | 84.23M -2.3M (-2.7%) | 2.31% -0.205 pp | 0.28% -0.010 pp | USD16.33 +32.9% | 7 qtrs — |
| 15 | JPMORGAN CHASE & CO | 3.63M -814.9K (-18.3%) | 78.85M -11.7M (-13.0%) | 2.21% -0.422 pp | 0.01% -0.001 pp | USD24.98 -13.1% | 26 qtrs — |
| 16 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 3.35M +444.7K (+15.3%) | 72.73M +13.5M (+22.9%) | 1.98% +0.261 pp | 0.02% +0.005 pp | USD33.82 -35.8% | 26 qtrs — |
| 17 | GEODE CAPITAL MANAGEMENT, LLC | 3.07M -39.0K (-1.3%) | 66.61M +3.3M (+5.2%) | 1.83% -0.012 pp | 0.00% +0.000 pp | USD29.85 -27.3% | 25 qtrs — |
| 18 | MILLENNIUM MANAGEMENT LLC | 2.42M +2.3M (+1,442.7%) | 52.55M +49.4M (+1,544.2%) | 1.44% +1.348 pp | 0.02% +0.021 pp | USD21.60 +0.5% | 26 qtrs — |
| 19 | AQR CAPITAL MANAGEMENT LLC | 2.36M +988.7K (+72.3%) | 51.17M +23.5M (+85.1%) | 1.43% +0.624 pp | 0.03% +0.009 pp | USD22.00 -1.3% | 21 qtrs — |
| 20 | PZENA INVESTMENT MANAGEMENT LLC | 2.33M -89.0K (-3.7%) | 50.49M +1.3M (+2.7%) | 1.41% -0.014 pp | 0.15% -0.008 pp | USD18.14 +19.7% | 5 qtrs — |
| 21 | BANK OF AMERICA CORP /DE/ | 2.32M +569.0 (+0.0%) | 50.37M +3.1M (+6.6%) | 1.38% +0.009 pp | 0.00% +0.001 pp | USD29.69 -26.9% | 26 qtrs — |
| 22 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.28M -13.5K (-0.6%) | 49.51M +2.8M (+5.9%) | 1.39% +0.030 pp | 0.63% -0.081 pp | USD18.46 +17.6% | 6 qtrs — |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.12M -67.3K (-3.1%) | 46.08M +1.5M (+3.3%) | 1.29% -0.005 pp | 0.01% +0.000 pp | USD29.93 -27.5% | 25 qtrs — |
| 24 | NORGES BANK | 2.08M +2.1M (+100.0%) | 45.11M +45.1M (+100.0%) | 1.24% +1.237 pp | 0.00% +0.005 pp | USD21.71 +0.0% | 1 qtrs NEW |
| 25 | JUPITER ASSET MANAGEMENT LTD | 2.00M +650.0K (+48.2%) | 43.40M +15.9M (+57.9%) | 1.19% +0.392 pp | 0.35% +0.112 pp | USD18.50 +17.4% | 7 qtrs — |
| 26 | QUANTINNO CAPITAL MANAGEMENT LP | 1.94M +1.1M (+131.1%) | 42.15M +25.0M (+146.4%) | 1.18% +0.684 pp | 0.08% +0.038 pp | USD20.93 +3.7% | 10 qtrs — |
| 27 | CITADEL ADVISORS LLC | 1.92M +220.9K (+13.0%) | 41.72M +7.1M (+20.4%) | 1.14% +0.138 pp | 0.01% +0.001 pp | USD20.52 +5.8% | 26 qtrs — |
| 28 | PARADICE INVESTMENT MANAGEMENT LLC | 1.71M -97.4K (-5.4%) | 37.11M +306.2K (+0.8%) | 1.01% -0.059 pp | 7.23% -1.026 pp | USD19.11 +13.6% | 24 qtrs — |
| 29 | NORTHERN TRUST CORP | 1.59M -96.7K (-5.7%) | 34.52M +161.4K (+0.5%) | 0.97% -0.031 pp | 0.00% +0.000 pp | USD27.83 -22.0% | 25 qtrs — |
| 30 | INVESCO LTD. | 1.55M +1.2M (+333.9%) | 33.58M +26.3M (+362.4%) | 0.92% +0.710 pp | 0.01% +0.004 pp | USD22.98 -5.5% | 25 qtrs — |
| 31 | FRONTIER CAPITAL MANAGEMENT CO LLC | 1.50M +188.8K (+14.4%) | 32.53M +5.9M (+21.9%) | 0.91% +0.137 pp | 0.35% +0.106 pp | USD24.76 -12.3% | 24 qtrs — |
| 32 | TWEEDY, BROWNE CO LLC | 1.44M -9.0K (-0.6%) | 31.33M +1.7M (+5.9%) | 0.85% -0.006 pp | 2.53% -0.040 pp | USD18.54 +17.1% | 8 qtrs — |
| 33 | GOTHAM ASSET MANAGEMENT, LLC | 1.41M +342.7K (+32.0%) | 30.71M +8.9M (+40.7%) | 0.86% +0.226 pp | 0.11% +0.017 pp | USD20.53 +5.7% | 21 qtrs — |
| 34 | FREESTONE GROVE PARTNERS LP | 1.34M +1.3M (+100.0%) | 29.05M +29.0M (+100.0%) | 0.81% +0.814 pp | 0.21% +0.210 pp | USD21.71 +0.0% | 1 qtrs NEW |
| 35 | BANK OF NEW YORK MELLON CORP | 1.31M -58.4K (-4.3%) | 28.48M +567.1K (+2.0%) | 0.78% -0.030 pp | 0.01% 0.000 pp | USD31.82 -31.8% | 25 qtrs — |
| 36 | IRON TRIANGLE PARTNERS LP | 1.19M +1.2M (+100.0%) | 25.76M +25.8M (+100.0%) | 0.72% +0.722 pp | 2.95% +2.946 pp | USD21.71 +0.0% | 6 qtrs — |
| 37 | PALISADE CAPITAL MANAGEMENT, LP | 1.07M -126.8K (-10.6%) | 23.24M -1.1M (-4.7%) | 0.65% -0.057 pp | 0.69% +0.026 pp | USD23.37 -7.1% | 14 qtrs — |
| 38 | GOLDMAN SACHS GROUP INC | 1.01M +297.4K (+41.6%) | 21.99M +7.4M (+50.9%) | 0.60% +0.180 pp | 0.00% +0.001 pp | USD23.31 -6.9% | 26 qtrs — |
| 39 | VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | 1.01M -1.0M (-50.5%) | 21.96M -19.7M (-47.2%) | 0.62% -0.594 pp | 0.19% -0.183 pp | USD21.44 +1.3% | 9 qtrs — |
| 40 | ROYCE & ASSOCIATES LP | 996.1K +103.3K (+11.6%) | 21.63M +3.4M (+18.9%) | 0.59% +0.065 pp | 0.22% +0.038 pp | USD19.57 +10.9% | 9 qtrs — |
| 41 | ARROWMARK COLORADO HOLDINGS LLC | 663.6K +— (+0.0%) | 14.41M +889.3K (+6.6%) | 0.40% +0.011 pp | 0.32% +0.066 pp | USD19.12 +13.5% | 6 qtrs — |
| 42 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 647.4K +490.1K (+311.4%) | 14.06M +10.9M (+338.4%) | 0.39% +0.301 pp | 0.01% +0.006 pp | USD21.36 +1.6% | 3 qtrs — |
| 43 | MARATHON ASSET MANAGEMENT LTD | 637.5K -62.0K (-8.9%) | 13.84M -407.9K (-2.9%) | 0.39% -0.026 pp | 0.53% +0.008 pp | USD22.15 -2.0% | 9 qtrs — |
| 44 | AMERIPRISE FINANCIAL INC | 619.9K +328.9K (+113.0%) | 13.46M +7.5M (+127.0%) | 0.38% +0.205 pp | 0.00% +0.002 pp | USD22.09 -1.7% | 26 qtrs — |
| 45 | UBS GROUP AG | 561.2K +7.7K (+1.4%) | 12.18M +908.8K (+8.1%) | 0.33% +0.007 pp | 0.00% +0.000 pp | USD19.80 +9.6% | 26 qtrs — |
| 46 | INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 500.0K -50.0K (-9.1%) | 10.86M -348.5K (-3.1%) | 0.30% -0.021 pp | 0.54% -0.219 pp | USD20.37 +6.6% | 2 qtrs — |
| 47 | LEEWARD INVESTMENTS, LLC - MA | 486.3K -12.2K (-2.4%) | 10.56M +403.0K (+4.0%) | 0.29% -0.008 pp | 0.53% +0.015 pp | USD48.35 -55.1% | 16 qtrs — |
| 48 | JANUS HENDERSON GROUP PLC | 475.8K -587.8K (-55.3%) | 10.33M -11.3M (-52.3%) | 0.29% -0.340 pp | 0.00% -0.005 pp | USD24.76 -12.3% | 25 qtrs — |
| 49 | UBS ASSET MANAGEMENT AMERICAS INC | 463.2K -25.0K (-5.1%) | 10.06M +111.3K (+1.1%) | 0.28% -0.007 pp | 0.00% +0.000 pp | USD19.67 +10.4% | 24 qtrs — |
| 50 | NEW YORK STATE COMMON RETIREMENT FUND | 451.6K +— (+0.0%) | 9.80M +605.2K (+6.6%) | 0.27% +0.002 pp | 0.01% +0.001 pp | USD23.20 -6.4% | 25 qtrs — |
| 51 | RHUMBLINE ADVISERS | 431.5K -22.2K (-4.9%) | 9.37M +125.2K (+1.4%) | 0.26% -0.012 pp | 0.01% +0.000 pp | USD36.73 -40.9% | 25 qtrs — |
| 52 | HEARTLAND ADVISORS INC | 429.0K -80.8K (-15.9%) | 9.31M -1.1M (-10.3%) | 0.26% -0.046 pp | 0.50% -0.047 pp | USD18.48 +17.5% | 5 qtrs — |
| 53 | SEI INVESTMENTS CO | 419.1K +33.2K (+8.6%) | 9.10M +1.2M (+15.7%) | 0.25% +0.027 pp | 0.01% +0.001 pp | USD25.27 -14.1% | 26 qtrs — |
| 54 | RENAISSANCE TECHNOLOGIES LLC | 408.3K -166.2K (-28.9%) | 8.86M -2.8M (-24.3%) | 0.24% -0.097 pp | 0.01% -0.002 pp | USD21.07 +3.0% | 10 qtrs — |
| 55 | TREXQUANT INVESTMENT LP | 387.4K +126.0K (+48.2%) | 8.41M +3.1M (+57.9%) | 0.24% +0.081 pp | 0.08% +0.020 pp | USD19.11 +13.6% | 13 qtrs — |
| 56 | PRINCIPAL FINANCIAL GROUP INC | 353.7K -15.7K (-4.2%) | 7.68M +155.2K (+2.1%) | 0.21% -0.010 pp | 0.00% +0.000 pp | USD45.40 -52.2% | 17 qtrs — |
| 57 | ALLIANZ ASSET MANAGEMENT GMBH | 340.5K -228.5K (-40.2%) | 7.39M -4.2M (-36.2%) | 0.20% -0.134 pp | 0.01% -0.006 pp | USD18.73 +15.9% | 5 qtrs — |
| 58 | RAYMOND JAMES FINANCIAL INC | 338.3K -13.2K (-3.8%) | 7.34M +184.6K (+2.6%) | 0.21% -0.002 pp | 0.00% +0.000 pp | USD19.09 +13.7% | 5 qtrs — |
| 59 | IEQ CAPITAL, LLC | 336.6K +208.7K (+163.2%) | 7.31M +4.7M (+180.5%) | 0.20% +0.129 pp | 0.02% +0.014 pp | USD21.05 +3.1% | 4 qtrs — |
| 60 | SWISS NATIONAL BANK | 327.6K -1.4K (-0.4%) | 7.11M +410.5K (+6.1%) | 0.20% +0.000 pp | 0.00% +0.000 pp | USD27.33 -20.6% | 25 qtrs — |
| 61 | HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 325.2K +1.4K (+0.4%) | 7.06M +464.4K (+7.0%) | 0.19% +0.002 pp | 0.02% +0.001 pp | USD19.72 +10.1% | 6 qtrs — |
| 62 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 317.3K -357.0 (-0.1%) | 6.89M +417.8K (+6.5%) | 0.19% +0.001 pp | 0.00% +0.000 pp | USD23.84 -8.9% | 25 qtrs — |
| 63 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 290.3K -142.0 (0.0%) | 6.30M +386.1K (+6.5%) | 0.17% 0.000 pp | 0.01% +0.000 pp | USD17.37 +25.0% | 4 qtrs — |
| 64 | FIRST TRUST ADVISORS LP | 267.6K +267.6K (+100.0%) | 5.81M +5.8M (+100.0%) | 0.16% +0.163 pp | 0.00% +0.004 pp | USD21.71 +0.0% | 1 qtrs NEW |
| 65 | LEGAL & GENERAL GROUP PLC | 251.0K -62.0K (-19.8%) | 5.45M -925.8K (-14.5%) | 0.15% -0.036 pp | 0.00% 0.000 pp | USD32.26 -32.7% | 26 qtrs — |
| 66 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 247.4K +29.4K (+13.5%) | 5.37M +929.7K (+20.9%) | 0.15% +0.022 pp | 0.02% +0.004 pp | USD20.16 +7.7% | 3 qtrs — |
| 67 | FIRST EAGLE INVESTMENT MANAGEMENT, LLC | 235.0K +22.5K (+10.6%) | 5.10M +773.2K (+17.9%) | 0.14% +0.013 pp | 0.01% +0.001 pp | USD20.50 +5.9% | 2 qtrs — |
| 68 | HOMESTEAD ADVISERS CORP | 223.0K +— (+0.0%) | 4.84M +298.8K (+6.6%) | 0.13% +0.001 pp | 0.13% +0.020 pp | USD21.53 +0.8% | 22 qtrs — |
| 69 | NUVEEN, LLC | 213.3K +— (+0.0%) | 4.63M +285.8K (+6.6%) | 0.13% +0.001 pp | 0.00% +0.000 pp | USD17.26 +25.8% | 4 qtrs — |
| 70 | RETIREMENT SYSTEMS OF ALABAMA | 197.3K -3.6K (-1.8%) | 4.28M +191.4K (+4.7%) | 0.12% -0.002 pp | 0.01% +0.000 pp | USD41.95 -48.2% | 19 qtrs — |
| 71 | QUBE RESEARCH & TECHNOLOGIES LTD | 180.4K +180.4K (+100.0%) | 3.92M +3.9M (+100.0%) | 0.11% +0.110 pp | 0.00% +0.004 pp | USD21.71 +0.0% | 1 qtrs NEW |
| 72 | AMUNDI | 169.8K +169.8K (+100.0%) | 3.69M +3.7M (+100.0%) | 0.10% +0.103 pp | 0.00% +0.001 pp | USD21.71 +0.0% | 1 qtrs NEW |
| 73 | HRT FINANCIAL LP | 163.5K +1.4K (+0.9%) | 3.55M +248.0K (+7.5%) | 0.10% +0.001 pp | 0.01% -0.001 pp | USD19.91 +9.0% | 3 qtrs — |
| 74 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 158.4K -458.0 (-0.3%) | 3.44M +202.9K (+6.3%) | 0.10% +0.002 pp | 0.00% +0.000 pp | USD28.83 -24.7% | 25 qtrs — |
| 75 | LOS ANGELES CAPITAL MANAGEMENT LLC | 167.8K +— (+0.0%) | 3.38M -38.6K (-1.1%) | 0.10% +0.001 pp | 0.01% 0.000 pp | USD20.37 +6.6% | 2 qtrs — |
| 76 | NATIXIS ADVISORS, L.P. | 147.8K -10.3K (-6.5%) | 3.21M -12.0K (-0.4%) | 0.09% -0.006 pp | 0.00% 0.000 pp | USD24.22 -10.4% | 25 qtrs — |
| 77 | STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 145.9K +— (+0.0%) | 3.17M +195.5K (+6.6%) | 0.09% +0.001 pp | 0.01% +0.000 pp | USD24.41 -11.1% | 25 qtrs — |
| 78 | MARSHALL WACE, LLP | 145.8K -213.7K (-59.4%) | 3.16M -4.2M (-56.8%) | 0.09% -0.126 pp | 0.00% -0.005 pp | USD23.45 -7.4% | 12 qtrs — |
| 79 | PRICE T ROWE ASSOCIATES INC /MD/ | 144.2K +3.9K (+2.8%) | 3.13M +273.0K (+9.6%) | 0.09% +0.005 pp | 0.00% +0.000 pp | USD26.03 -16.6% | 26 qtrs — |
| 80 | MAGNETAR FINANCIAL LLC | 142.7K +85.9K (+151.4%) | 3.10M +1.9M (+167.9%) | 0.09% +0.053 pp | 0.03% +0.023 pp | USD21.18 +2.5% | 4 qtrs — |
| 81 | VERITION FUND MANAGEMENT LLC | 139.0K -25.1K (-15.3%) | 3.02M -325.3K (-9.7%) | 0.08% -0.013 pp | 0.01% -0.002 pp | USD18.49 +17.4% | 22 qtrs — |
| 82 | MUBADALA INVESTMENT CO PJSC | 130.6K +— (+0.0%) | 2.84M +175.0K (+6.6%) | 0.08% +0.002 pp | 0.02% +0.001 pp | USD20.37 +6.6% | 2 qtrs — |
| 83 | HANTZ FINANCIAL SERVICES, INC. | 128.2K -13.7K (-9.6%) | 2.78M -107.0K (-3.7%) | 0.08% -0.008 pp | 0.04% -0.003 pp | USD22.88 -5.1% | 19 qtrs — |
| 84 | BRIDGEWATER ASSOCIATES, LP | 124.1K +45.7K (+58.3%) | 2.69M +1.1M (+68.7%) | 0.08% +0.029 pp | 0.01% +0.004 pp | USD20.86 +4.1% | 2 qtrs — |
| 85 | TWO SIGMA ADVISERS, LP | 123.7K +61.6K (+99.2%) | 2.69M +1.4M (+112.3%) | 0.07% +0.037 pp | 0.01% +0.003 pp | USD21.04 +3.2% | 20 qtrs — |
| 86 | BARCLAYS PLC | 117.0K -724.6K (-86.1%) | 2.54M -14.1M (-84.7%) | 0.07% -0.428 pp | 0.00% -0.004 pp | USD20.42 +6.3% | 16 qtrs — |
| 87 | INTECH INVESTMENT MANAGEMENT LLC | 115.2K +115.2K (+100.0%) | 2.50M +2.5M (+100.0%) | 0.07% +0.069 pp | 0.02% +0.022 pp | USD21.71 +0.0% | 1 qtrs NEW |
| 88 | WALLEYE CAPITAL LLC | 114.4K +114.4K (+100.0%) | 2.48M +2.5M (+100.0%) | 0.07% +0.070 pp | 0.01% +0.008 pp | USD21.71 +0.0% | 1 qtrs NEW |
| 89 | ALGERT GLOBAL LLC | 113.2K +113.2K (+100.0%) | 2.46M +2.5M (+100.0%) | 0.07% +0.069 pp | 0.04% +0.038 pp | USD21.71 +0.0% | 1 qtrs NEW |
| 90 | COMERICA BANK | 113.0K +14.2K (+14.4%) | 2.45M +441.5K (+21.9%) | 0.07% +0.008 pp | 0.01% +0.002 pp | USD26.01 -16.5% | 11 qtrs — |
| 91 | STATE OF NEW JERSEY COMMON PENSION FUND D | 112.7K +8.8K (+8.5%) | 2.45M +330.0K (+15.6%) | 0.07% +0.005 pp | 0.01% +0.001 pp | USD21.56 +0.7% | 23 qtrs — |
| 92 | WELLINGTON MANAGEMENT GROUP LLP | 112.1K +112.1K (+100.0%) | 2.43M +2.4M (+100.0%) | 0.07% +0.068 pp | 0.00% +0.000 pp | USD21.71 +0.0% | 3 qtrs — |
| 93 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 111.4K -4.2K (-3.6%) | 2.42M +63.4K (+2.7%) | 0.07% -0.001 pp | 0.00% +0.000 pp | USD29.27 -25.8% | 19 qtrs — |
| 94 | RUSSELL INVESTMENTS GROUP, LTD. | 106.3K -15.4K (-12.6%) | 2.31M -169.9K (-6.9%) | 0.06% -0.007 pp | 0.00% 0.000 pp | USD23.59 -8.0% | 25 qtrs — |
| 95 | PATHSTONE HOLDINGS, LLC | 102.3K +4.2K (+4.2%) | 2.22M +221.7K (+11.1%) | 0.06% +0.003 pp | 0.01% +0.001 pp | USD19.15 +13.4% | 9 qtrs — |
| 96 | TEACHER RETIREMENT SYSTEM OF TEXAS | 98.4K +3.8K (+4.1%) | 2.14M +210.2K (+10.9%) | 0.06% +0.002 pp | 0.01% 0.000 pp | USD19.08 +13.8% | 5 qtrs — |
| 97 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 97.0K -3.5K (-3.5%) | 2.11M +58.8K (+2.9%) | 0.06% -0.001 pp | 0.01% +0.000 pp | USD27.58 -21.3% | 25 qtrs — |
| 98 | — | 97.0K +97.0K (+100.0%) | 2.10M +2.1M (+100.0%) | 0.06% +0.059 pp | 0.12% +0.125 pp | USD21.71 +0.0% | 1 qtrs NEW |
| 99 | BALYASNY ASSET MANAGEMENT L.P. | 95.7K -1.1M (-92.0%) | 2.08M -22.2M (-91.4%) | 0.06% -0.647 pp | 0.00% -0.028 pp | USD20.37 +6.6% | 14 qtrs — |
| 100 | GREAT WEST LIFE ASSURANCE CO /CAN/ | 94.9K -45.4K (-32.4%) | 2.06M -778.0K (-27.4%) | 0.06% -0.025 pp | 0.00% -0.001 pp | USD33.68 -35.5% | 25 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
2.82
Bullish
Ratio by volume
3.00
Bullish
Buys
31
Sells
11
Shares acquired
631.6K
Shares disposed
44.3K
Cash buys
—
Cash sales
1.00
Net activity
+587,334
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-25 | Reis Mischa | Officer | A-Award | A | Performance Share Unit | 10,770 | 0.00 | — | 10,770 | D | ↗ |
| 2026-02-25 | Nilsson Stefan | Officer | A-Award | A | Common Stock | 7,605 | 0.00 | — | 62,364 | D | ↗ |
| 2026-02-25 | Nance Mark E | Officer | A-Award | A | Performance Share Unit | 23,070 | 0.00 | — | 23,070 | D | ↗ |
| 2026-02-25 | Keel Paul A | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 115,320 | 29.59 | 3.41M | 115,320 | D | ↗ |
| 2026-02-25 | Kaabi Faez C | Officer | F-InKind | D | Common Stock | 4,964 | 29.59 | 146.9K | 45,032 | D | ↗ |
| 2026-02-25 | Hammes Eric D. | Officer | A-Award | A | Common Stock | 16,055 | 0.00 | — | 110,798 | D | ↗ |
| 2026-02-25 | Befidi Robert | Officer | A-Award | A | Performance Share Unit | 13,845 | 0.00 | — | 13,845 | D | ↗ |
| 2026-02-25 | Acurio Veronica | Officer | A-Award | A | Performance Share Unit | 13,845 | 0.00 | — | 13,845 | D | ↗ |
| 2026-02-10 | Reis Mischa | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 5,634 | 15.97 | 90.0K | 0 | D | ↗ |
| 2026-02-01 | Reis Mischa | Officer | A-Award | A | Executive Deferred Incentive Program - Envista Stock Fund | 2,919 | 0.00 | — | 29,357 | D | ↗ |
| 2026-02-01 | Nance Mark E | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 2,006 | 0.00 | — | 7,587 | D | ↗ |
| 2026-02-01 | Keel Paul A | Director / Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 4,091 | 0.00 | — | 4,091 | D | ↗ |
| 2026-02-01 | Kaabi Faez C | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 1,186 | 0.00 | — | 5,040 | D | ↗ |
| 2026-02-01 | Hammes Eric D. | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 1,119 | 0.00 | — | 1,119 | D | ↗ |
| 2026-02-01 | Befidi Robert | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 998 | 0.00 | — | 2,149 | D | ↗ |
| 2026-02-01 | Acurio Veronica | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 998 | 0.00 | — | 998 | D | ↗ |
| 2025-11-01 | Keel Paul A | Director / Officer | F-InKind | D | Common Stock | 54,097 | 20.35 | 1.10M | 347,555 | D | ↗ |
| 2025-08-25 | Reis Mischa | Officer | S-Sale | D | Common Stock | 15,000 | 21.60 | 324.0K | 32,382 | D | ↗ |
| 2025-08-25 | Nilsson Stefan | Officer | F-InKind | D | Common Stock | 804 | 21.12 | 17.0K | 54,941 | D | ↗ |
| 2025-08-25 | Hammes Eric D. | Officer | F-InKind | D | Common Stock | 7,654 | 21.12 | 161.7K | 96,788 | D | ↗ |
| 2025-08-25 | Befidi Robert | Officer | F-InKind | D | Common Stock | 3,454 | 21.12 | 72.9K | 45,504 | D | ↗ |
| 2025-08-25 | Acurio Veronica | Officer | F-InKind | D | Common Stock | 5,422 | 21.12 | 114.5K | 50,323 | D | ↗ |
| 2025-07-14 | Pierce James Andrew | Director | A-Award | A | Common Stock | 9,155 | 0.00 | — | 9,155 | D | ↗ |
| 2025-06-10 | TSINGOS CHRISTINE A | Director | A-Award | A | Common Stock | 10,450 | 0.00 | — | 50,600 | D | ↗ |
| 2025-06-10 | Raskas Daniel | Director | A-Award | A | Common Stock | 10,450 | 0.00 | — | 44,680 | D | ↗ |
| 2025-06-10 | Jain Vivek | Director | A-Award | A | Common Stock | 10,450 | 0.00 | — | 43,615 | D | ↗ |
| 2025-06-10 | Hulit Barbara B. | Director | A-Award | A | Common Stock | 10,450 | 0.00 | — | 79,820 | D | ↗ |
| 2025-06-10 | Huennekens R Scott | Director | A-Award | A | Common Stock | 14,370 | 0.00 | — | 69,520 | D | ↗ |
| 2025-06-10 | GALLAHUE KIERAN | Director | A-Award | A | Common Stock | 10,450 | 0.00 | — | 44,680 | D | ↗ |
| 2025-06-10 | Carruthers Wendy | Director | A-Award | A | Common Stock | 10,450 | 0.00 | — | 50,610 | D | ↗ |
| 2025-05-25 | Keel Paul A | Director / Officer | F-InKind | D | Common Stock | 12,787 | 16.72 | 213.8K | 401,652 | D | ↗ |
| 2025-02-26 | Reis Mischa | Officer | A-Award | A | Common Stock | 8,475 | 0.00 | — | 47,382 | D | ↗ |
| 2025-02-25 | Reis Mischa | Officer | A-Award | A | Performance Share Unit | 15,615 | 0.00 | — | 15,615 | D | ↗ |
| 2025-02-25 | Nilsson Stefan | Officer | A-Award | A | Performance Share Unit | 18,960 | 0.00 | — | 18,960 | D | ↗ |
| 2025-02-25 | Nance Mark E | Officer | A-Award | A | Common Stock | 18,155 | 0.00 | — | 71,945 | D | ↗ |
| 2025-02-25 | Keel Paul A | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 153,660 | 20.66 | 3.17M | 153,660 | D | ↗ |
| 2025-02-25 | Kaabi Faez C | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 22,600 | 20.66 | 466.9K | 22,600 | D | ↗ |
| 2025-02-25 | Hammes Eric D. | Officer | A-Award | A | Common Stock | 15,735 | 0.00 | — | 104,442 | D | ↗ |
| 2025-02-25 | Befidi Robert | Officer | A-Award | A | Common Stock | 10,290 | 0.00 | — | 48,958 | D | ↗ |
| 2025-02-25 | Acurio Veronica | Officer | A-Award | A | Performance Share Unit | 18,960 | 0.00 | — | 18,960 | D | ↗ |
| 2025-02-01 | Reis Mischa | Officer | A-Award | A | Executive Deferred Incentive Program - Envista Stock Fund | 3,152 | 0.00 | — | 26,438 | D | ↗ |
| 2025-02-01 | Nance Mark E | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 965 | 0.00 | — | 5,581 | D | ↗ |
| 2025-02-01 | Kaabi Faez C | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 689 | 0.00 | — | 3,854 | D | ↗ |
| 2025-02-01 | Befidi Robert | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 1,151 | 0.00 | — | 1,151 | D | ↗ |
| 2024-11-18 | Nilsson Stefan | Officer | — | — | Common Stock | 0 | 0.00 | — | 45,455 | D | ↗ |
| 2024-11-18 | Acurio Veronica | Officer | — | — | Common Stock | 0 | 0.00 | — | 45,455 | D | ↗ |
| 2024-11-01 | Keel Paul A | Director / Officer | F-InKind | D | Common Stock | 53,996 | 20.94 | 1.13M | 348,609 | D | ↗ |
| 2024-09-17 | Reis Mischa | Officer | F-InKind | D | Common Stock | 812 | 19.00 | 15.4K | 42,720 | — | ↗ |
| 2024-08-25 | Reis Mischa | Officer | A-Award | A | Performance Option | 57,980 | 18.70 | 1.08M | 57,980 | — | ↗ |
| 2024-08-25 | Nance Mark E | Officer | A-Award | A | Performance Option | 95,240 | 18.70 | 1.78M | 95,240 | — | ↗ |
| 2024-08-25 | Keel Paul A | Director / Officer | A-Award | A | Performance Option | 485,680 | 18.70 | 9.08M | 485,680 | — | ↗ |
| 2024-08-25 | Hammes Eric D. | Officer | A-Award | A | Common Stock | 64,175 | 0.00 | — | 88,707 | — | ↗ |
| 2024-08-25 | Befidi Robert | Officer | A-Award | A | Performance Option | 70,400 | 18.70 | 1.32M | 70,400 | — | ↗ |
| 2024-08-13 | Keel Paul A | Director / Officer | P-Purchase | A | Common Stock | 30,000 | 16.87 | 506.1K | 402,605 | — | ↗ |
| 2024-08-12 | Hammes Eric D. | Officer | P-Purchase | A | Common Stock | 24,532 | 16.33 | 400.6K | 24,532 | — | ↗ |
| 2024-08-08 | Hammes Eric D. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-07-15 | Nance Mark E | Officer | F-InKind | D | Common Stock | 491 | 15.94 | 7.8K | 57,481 | — | ↗ |
| 2024-06-25 | Keller Stephen | Officer | A-Award | A | Common Stock | 31,250 | 0.00 | — | 53,803 | — | ↗ |
| 2024-05-25 | Keel Paul A | Director / Officer | A-Award | A | Common Stock | 71,235 | 0.00 | — | 71,235 | — | ↗ |
| 2024-05-25 | Conley Eric | Officer | F-InKind | D | Common Stock | 642 | 18.25 | 11.7K | 53,223 | — | ↗ |
| 2024-05-21 | TSINGOS CHRISTINE A | Director | A-Award | A | Common Stock | 10,085 | 0.00 | — | 40,150 | — | ↗ |
| 2024-05-21 | Raskas Daniel | Director | A-Award | A | Common Stock | 10,085 | 0.00 | — | 34,230 | — | ↗ |
| 2024-05-21 | Jain Vivek | Director | A-Award | A | Common Stock | 10,085 | 0.00 | — | 33,165 | — | ↗ |
| 2024-05-21 | Hulit Barbara B. | Director | A-Award | A | Common Stock | 10,085 | 0.00 | — | 69,370 | — | ↗ |
| 2024-05-21 | Huennekens R Scott | Director | A-Award | A | Common Stock | 14,170 | 0.00 | — | 55,150 | — | ↗ |
| 2024-05-21 | GALLAHUE KIERAN | Director | A-Award | A | Common Stock | 10,085 | 0.00 | — | 34,230 | — | ↗ |
| 2024-05-21 | Carruthers Wendy | Director | A-Award | A | Common Stock | 10,085 | 0.00 | — | 40,160 | — | ↗ |
| 2024-05-01 | Keel Paul A | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-04-15 | Hulit Barbara B. | Director | A-Award | A | Common Stock | 13,065 | 0.00 | — | 59,285 | — | ↗ |
| 2024-03-15 | Hulit Barbara B. | Director | A-Award | A | Common Stock | 11,705 | 0.00 | — | 46,220 | — | ↗ |
| 2024-02-25 | Reis Mischa | Officer | A-Award | A | Common Stock | 16,565 | 0.00 | — | 43,532 | — | ↗ |
| 2024-02-25 | Nance Mark E | Officer | A-Award | A | Performance Share Unit | 23,350 | 0.00 | — | 23,350 | — | ↗ |
| 2024-02-25 | Keller Stephen | Officer | A-Award | A | Common Stock | 11,045 | 0.00 | — | 22,553 | — | ↗ |
| 2024-02-25 | Kaabi Faez C | Officer | F-InKind | D | Common Stock | 1,505 | 22.65 | 34.1K | 13,715 | — | ↗ |
| 2024-02-25 | Conley Eric | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 18,040 | 22.65 | 408.6K | 18,040 | — | ↗ |
| 2024-02-25 | Befidi Robert | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 21,910 | 22.65 | 496.3K | 21,910 | — | ↗ |
| 2024-02-25 | Aghdaei Amir | Director / Officer | A-Award | A | Common Stock | 48,570 | 0.00 | — | 310,565 | — | ↗ |
| 2024-02-15 | Hulit Barbara B. | Director | A-Award | A | Common Stock | 22,225 | 0.00 | — | 34,515 | — | ↗ |
| 2024-02-12 | Befidi Robert | Officer | — | D | Common Stock | 0 | 0.00 | — | 33,860 | — | ↗ |
| 2024-02-01 | Reis Mischa | Officer | A-Award | A | Executive Deferred Incentive Program - Envista Stock Fund | 2,528 | 0.00 | — | 23,286 | — | ↗ |
| 2024-02-01 | Nance Mark E | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 1,498 | 0.00 | — | 4,616 | — | ↗ |
| 2024-02-01 | Keller Stephen | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 548 | 0.00 | — | 1,759 | — | ↗ |
| 2024-02-01 | Kaabi Faez C | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 754 | 0.00 | — | 3,165 | — | ↗ |
| 2024-02-01 | Conley Eric | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 1,219 | 0.00 | — | 4,706 | — | ↗ |
| 2024-02-01 | Aghdaei Amir | Director / Officer | A-Award | A | Executive Deferred Incentive Program - Envista Stock Fund | 10,287 | 0.00 | — | 86,300 | — | ↗ |
| 2023-11-16 | Conley Eric | Officer | P-Purchase | A | Common Stock | 2 | 22.90 | 45.80 | 47,376 | — | ↗ |
| 2023-11-08 | Nance Mark E | Officer | P-Purchase | A | Common Stock | 5,000 | 21.75 | 108.8K | 39,042 | — | ↗ |
| 2023-11-06 | Keller Stephen | Officer | P-Purchase | A | Common Stock | 2,000 | 21.53 | 43.1K | 13,070 | — | ↗ |
| 2023-11-06 | Aghdaei Amir | Director / Officer | P-Purchase | A | Common Stock | 600 | 21.52 | 12.9K | 293,764 | — | ↗ |
| 2023-09-22 | Keller Stephen | Officer | — | D | Common Stock | 0 | 0.00 | — | 207 | — | ↗ |
| 2023-09-22 | Kaabi Faez C | Officer | — | D | Employee Stock Option (Right to Buy) | 5,750 | 48.52 | 279.0K | 0 | — | ↗ |
| 2023-09-17 | Yu Howard H | Officer | F-InKind | D | Common Stock | 1,965 | 28.87 | 56.7K | 43,900 | — | ↗ |
| 2023-09-17 | Reis Mischa | Officer | F-InKind | D | Common Stock | 787 | 28.87 | 22.7K | 31,101 | — | ↗ |
| 2023-09-17 | Eriksson Patrik | Officer | F-InKind | D | Common Stock | 1,298 | 28.87 | 37.5K | 79,686 | — | ↗ |
| 2023-09-17 | Aghdaei Amir | Director / Officer | F-InKind | D | Common Stock | 18,394 | 28.87 | 531.0K | 285,362 | — | ↗ |
| 2023-07-15 | Nance Mark E | Officer | F-InKind | D | Common Stock | 492 | 35.07 | 17.3K | 34,042 | — | ↗ |
| 2023-07-15 | Aghdaei Amir | Director / Officer | F-InKind | D | Common Stock | 13,250 | 35.07 | 464.7K | 303,756 | — | ↗ |
| 2023-05-25 | Conley Eric | Officer | F-InKind | D | Common Stock | 642 | 32.95 | 21.2K | 45,191 | — | ↗ |
| 2023-05-23 | TSINGOS CHRISTINE A | Director | A-Award | A | Common Stock | 5,425 | 0.00 | — | 30,065 | — | ↗ |
| 2023-05-23 | Raskas Daniel | Director | A-Award | A | Common Stock | 5,425 | 0.00 | — | 24,145 | — | ↗ |
| 2023-05-23 | Jain Vivek | Director | A-Award | A | Common Stock | 5,425 | 0.00 | — | 23,080 | — | ↗ |
| 2023-05-23 | Hulit Barbara B. | Director | A-Award | A | Common Stock | 5,425 | 0.00 | — | 12,290 | — | ↗ |
| 2023-05-23 | Huennekens R Scott | Director | A-Award | A | Common Stock | 7,625 | 0.00 | — | 40,980 | — | ↗ |
| 2023-05-23 | GALLAHUE KIERAN | Director | A-Award | A | Common Stock | 5,425 | 0.00 | — | 24,145 | — | ↗ |
| 2023-05-23 | Carruthers Wendy | Director | A-Award | A | Common Stock | 5,425 | 0.00 | — | 30,075 | — | ↗ |
| 2023-05-12 | Conley Eric | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 9 | 0.00 | — | 3,487 | — | ↗ |
| 2023-04-28 | Conley Eric | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 8 | 0.00 | — | 3,478 | — | ↗ |
| 2023-04-14 | Conley Eric | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 0 | 0.00 | — | 3,470 | — | ↗ |
| 2023-04-04 | Yu Howard H | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 1,513 | 0.00 | — | 3,871 | — | ↗ |
| 2023-04-04 | Reis Mischa | Officer | A-Award | A | Executive Deferred Incentive Program - Envista Stock Fund | 1,730 | 0.00 | — | 20,758 | — | ↗ |
| 2023-04-04 | Nance Mark E | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 1,308 | 0.00 | — | 3,118 | — | ↗ |
| 2023-04-04 | Kyrillos Jean-Claude | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 516 | 0.00 | — | 1,431 | — | ↗ |
| 2023-04-04 | Eriksson Patrik | Officer | A-Award | A | Executive Deferred Incentive Program - Envista Stock Fund | 2,222 | 0.00 | — | 42,099 | — | ↗ |
| 2023-04-04 | Conley Eric | Officer | A-Award | A | Envista deferred contribution programs - Envista Stock Fund | 928 | 0.00 | — | 3,462 | — | ↗ |
| 2023-04-04 | Aghdaei Amir | Director / Officer | A-Award | A | Executive Deferred Incentive Program - Envista Stock Fund | 5,881 | 0.00 | — | 76,013 | — | ↗ |
| 2023-02-28 | Yu Howard H | Officer | S-Sale | D | Common Stock | 10,016 | 37.90 | 379.6K | 45,865 | — | ↗ |
| 2023-02-25 | Yu Howard H | Officer | A-Award | A | Common Stock | 10,295 | 0.00 | — | 55,881 | — | ↗ |
| 2023-02-25 | Reis Mischa | Officer | A-Award | A | Performance Share Unit | 8,315 | 0.00 | — | 8,315 | — | ↗ |
| 2023-02-25 | Nance Mark E | Officer | A-Award | A | Performance Share Unit | 11,280 | 0.00 | — | 11,280 | — | ↗ |
| 2023-02-25 | Kyrillos Jean-Claude | Officer | A-Award | A | Common Stock | 5,560 | 0.00 | — | 27,838 | — | ↗ |
| 2023-02-25 | Eriksson Patrik | Officer | A-Award | A | Performance Share Unit | 10,095 | 0.00 | — | 10,095 | — | ↗ |
| 2023-02-25 | Conley Eric | Officer | A-Award | A | Common Stock | 16,995 | 0.00 | — | 45,833 | — | ↗ |
| 2023-02-25 | Aghdaei Amir | Director / Officer | A-Award | A | Common Stock | 27,190 | 0.00 | — | 317,006 | — | ↗ |
| 2023-02-24 | Yu Howard H | Officer | F-InKind | D | Common Stock | 1,803 | 38.25 | 69.0K | 49,303 | — | ↗ |
| 2023-02-24 | Reis Mischa | Officer | F-InKind | D | Common Stock | 1,913 | 38.25 | 73.2K | 29,259 | — | ↗ |
| 2023-02-24 | Eriksson Patrik | Officer | F-InKind | D | Common Stock | 3,414 | 38.25 | 130.6K | 78,331 | — | ↗ |
| 2023-02-24 | Aghdaei Amir | Director / Officer | F-InKind | D | Common Stock | 38,121 | 38.25 | 1.46M | 313,333 | — | ↗ |
| 2023-02-13 | Conley Eric | Officer | — | D | Envista deferred contribution programs - Envista Stock Fund | 1,742 | 0.00 | — | 0 | — | ↗ |
| 2022-11-17 | Yu Howard H | Officer | S-Sale | D | Common Stock | 657 | 36.55 | 24.0K | 51,106 | — | ↗ |
| 2022-11-15 | Yu Howard H | Officer | F-InKind | D | Common Stock | 648 | 37.76 | 24.5K | 51,763 | — | ↗ |
| 2022-07-15 | Nance Mark E | Officer | F-InKind | D | Common Stock | 540 | 38.79 | 20.9K | 30,345 | — | ↗ |
| 2022-07-15 | Aghdaei Amir | Officer | F-InKind | D | Common Stock | 13,325 | 38.79 | 516.9K | 351,454 | — | ↗ |
| 2022-05-24 | TSINGOS CHRISTINE A | Director | A-Award | A | Common Stock | 4,435 | 0.00 | — | 24,640 | — | ↗ |
| 2022-05-24 | Raskas Daniel | Director | A-Award | A | Common Stock | 4,435 | 0.00 | — | 18,720 | — | ↗ |
| 2022-05-24 | Jain Vivek | Director | A-Award | A | Common Stock | 4,435 | 0.00 | — | 17,655 | — | ↗ |
| 2022-05-24 | Hulit Barbara B. | Director | A-Award | A | Common Stock | 4,435 | 0.00 | — | 6,865 | — | ↗ |
| 2022-05-24 | Huennekens R Scott | Director | A-Award | A | Common Stock | 5,930 | 0.00 | — | 33,355 | — | ↗ |
| 2022-05-24 | GALLAHUE KIERAN | Director | A-Award | A | Common Stock | 4,435 | 0.00 | — | 18,720 | — | ↗ |
| 2022-05-24 | Carruthers Wendy | Director | A-Award | A | Common Stock | 4,435 | 0.00 | — | 24,650 | — | ↗ |
| 2022-05-13 | Reis Mischa | Officer | F-InKind | D | Common Stock | 155 | 41.75 | 6.5K | 31,172 | — | ↗ |
| 2022-04-18 | Yu Howard H | Officer | S-Sale | D | Common Stock | 5,341 | 45.73 | 244.2K | 52,411 | — | ↗ |
| 2022-03-29 | Aghdaei Amir | Officer | S-Sale | D | Common Stock | 3,801 | 51.50 | 195.8K | 364,779 | — | ↗ |
| 2022-03-21 | Yu Howard H | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 1,930 | 21.76 | 42.0K | 13,804 | — | ↗ |
| 2022-03-21 | Eriksson Patrik | Officer | I-Discretionary | A | Common Stock | 4,005 | 47.26 | 189.3K | 4,005 | — | ↗ |
| 2022-03-18 | Yu Howard H | Officer | M-Exempt | A | Common Stock | 7,272 | 21.76 | 158.2K | 65,024 | — | ↗ |
| 2022-03-18 | Reis Mischa | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 10,092 | 19.04 | 192.2K | 4,041 | — | ↗ |
| 2022-03-18 | Aghdaei Amir | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 114,702 | 0.00 | — | 2,195 | — | ↗ |
| 2022-03-16 | Aghdaei Amir | Officer | S-Sale | D | Common Stock | 8,982 | 47.75 | 428.9K | 390,923 | — | ↗ |
| 2022-03-01 | Reis Mischa | Officer | S-Sale | D | Common Stock | 2,958 | 47.83 | 141.5K | 31,327 | — | ↗ |
| 2022-03-01 | Bludworth Curt W | Officer | S-Sale | D | Common Stock | 4,181 | 47.83 | 200.0K | 46,759 | — | ↗ |
| 2022-02-25 | Yu Howard H | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 21,560 | 48.52 | 1.05M | 21,560 | — | ↗ |
| 2022-02-25 | Reis Mischa | Officer | F-InKind | D | Common Stock | 1,565 | 48.52 | 75.9K | 35,213 | — | ↗ |
| 2022-02-25 | Nance Mark E | Officer | A-Award | A | Common Stock | 4,640 | 0.00 | — | 30,885 | — | ↗ |
| 2022-02-25 | Moore Kari Lyn | Officer | A-Award | A | Common Stock | 3,610 | 0.00 | — | 25,311 | — | ↗ |
| 2022-02-25 | Kyrillos Jean-Claude | Officer | A-Award | A | Common Stock | 4,380 | 0.00 | — | 25,074 | — | ↗ |
| 2022-02-25 | Eriksson Patrik | Officer | A-Award | A | Performance Share Unit | 7,960 | 0.00 | — | 7,960 | — | ↗ |
| 2022-02-25 | Bludworth Curt W | Officer | S-Sale | D | Common Stock | 8,446 | 47.71 | 403.0K | 50,940 | — | ↗ |
| 2022-02-25 | Aghdaei Amir | Director / Officer | A-Award | A | Common Stock | 21,025 | 0.00 | — | 399,905 | — | ↗ |
| 2022-02-24 | Yu Howard H | Officer | F-InKind | D | Common Stock | 2,136 | 47.36 | 101.2K | 56,446 | — | ↗ |
| 2022-02-24 | Reis Mischa | Officer | F-InKind | D | Common Stock | 2,265 | 47.36 | 107.3K | 36,778 | — | ↗ |
| 2022-02-24 | Eriksson Patrik | Officer | F-InKind | D | Common Stock | 4,026 | 47.36 | 190.7K | 79,767 | — | ↗ |
| 2022-02-24 | Bludworth Curt W | Officer | F-InKind | D | Common Stock | 2,824 | 47.36 | 133.7K | 60,734 | — | ↗ |
| 2022-02-24 | Aghdaei Amir | Director / Officer | F-InKind | D | Common Stock | 38,472 | 47.36 | 1.82M | 396,252 | — | ↗ |
| 2022-02-11 | Reis Mischa | Officer | M-Exempt | A | Common Stock | 6,056 | 19.04 | 115.3K | 45,099 | — | ↗ |
| 2021-12-31 | Hulit Barbara B. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-28 | Aghdaei Amir | Director / Officer | M-Exempt | A | Common Stock | 2,900 | 15.27 | 44.3K | 440,033 | — | ↗ |
| 2021-12-27 | Aghdaei Amir | Director / Officer | S-Sale | D | Common Stock | 6,700 | 46.76 | 313.3K | 439,634 | — | ↗ |
| 2021-12-23 | Yu Howard H | Officer | M-Exempt | A | Common Stock | 3,954 | 19.49 | 77.1K | 62,536 | — | ↗ |
| 2021-12-23 | Reis Mischa | Officer | M-Exempt | A | Common Stock | 10,016 | 16.51 | 165.4K | 49,059 | — | ↗ |
| 2021-12-23 | Bludworth Curt W | Officer | S-Sale | D | Common Stock | 13,354 | 45.00 | 600.9K | 63,558 | — | ↗ |
| 2021-12-22 | Aghdaei Amir | Director / Officer | S-Sale | D | Common Stock | 8,434 | 44.75 | 377.4K | 463,063 | — | ↗ |
| 2021-12-01 | Hulit Barbara B. | Director | — | D | Common Stock | 0 | 0.00 | — | 2,425 | — | ↗ |
| 2021-11-25 | Moore Kari Lyn | Officer | F-InKind | D | Common Stock | 1,814 | 41.58 | 75.4K | 22,784 | — | ↗ |
| 2021-11-17 | Yu Howard H | Officer | S-Sale | D | Common Stock | 657 | 42.30 | 27.8K | 58,582 | — | ↗ |
| 2021-11-17 | Kappler Jeffrey | Officer | S-Sale | D | Common Stock | 153 | 42.30 | 6.5K | 37,336 | — | ↗ |
| 2021-11-15 | Yu Howard H | Officer | F-InKind | D | Common Stock | 648 | 42.79 | 27.7K | 59,239 | — | ↗ |
| 2021-11-15 | Kappler Jeffrey | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 511 | 15.27 | 7.8K | 0 | — | ↗ |
| 2021-11-15 | Aghdaei Amir | Director / Officer | F-InKind | D | Common Stock | 10,029 | 42.79 | 429.1K | 471,497 | — | ↗ |
| 2021-10-25 | Kyrillos Jean-Claude | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 189,900 | 38.46 | 7.30M | 189,900 | — | ↗ |
| 2021-09-14 | Nance Mark E | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 4,321 | 27.05 | 116.9K | 17,717 | — | ↗ |
| 2021-09-02 | Nance Mark E | Officer | M-Exempt | A | Common Stock | 980 | 27.05 | 26.5K | 28,862 | — | ↗ |
| 2021-08-27 | Reis Mischa | Officer | S-Sale | D | Common Stock | 10,016 | 42.50 | 425.7K | 39,043 | — | ↗ |
| 2021-08-04 | Kappler Jeffrey | Officer | S-Sale | D | Common Stock | 47 | 44.25 | 2.1K | 38,090 | — | ↗ |
| 2021-08-03 | Nance Mark E | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 304 | 27.05 | 8.2K | 23,018 | — | ↗ |
| 2021-08-02 | Nance Mark E | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 300 | 27.05 | 8.1K | 23,322 | — | ↗ |
| 2021-07-16 | Kappler Jeffrey | Officer | M-Exempt | A | Common Stock | 1,658 | 16.30 | 27.0K | 39,854 | — | ↗ |
| 2021-07-15 | Nance Mark E | Officer | F-InKind | D | Common Stock | 540 | 41.91 | 22.6K | 27,882 | — | ↗ |
| 2021-07-15 | Kappler Jeffrey | Officer | F-InKind | D | Common Stock | 231 | 41.91 | 9.7K | 38,196 | — | ↗ |
| 2021-07-15 | Aghdaei Amir | Director / Officer | F-InKind | D | Common Stock | 11,958 | 41.91 | 501.2K | 481,526 | — | ↗ |
| 2021-06-11 | Nance Mark E | Officer | M-Exempt | A | Common Stock | 8,358 | 26.50 | 221.5K | 36,780 | — | ↗ |
| 2021-06-11 | Bludworth Curt W | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 14,654 | 12.65 | 185.4K | 0 | — | ↗ |
| 2021-06-07 | Bludworth Curt W | Officer | M-Exempt | A | Common Stock | 6,740 | 12.62 | 85.1K | 72,765 | — | ↗ |
| 2021-05-25 | TSINGOS CHRISTINE A | Director | A-Award | A | Common Stock | 4,020 | 0.00 | — | 20,205 | — | ↗ |
| 2021-05-25 | Sheppard Teresa Gayle | Director | A-Award | A | Common Stock | 4,020 | 0.00 | — | 10,480 | — | ↗ |
| 2021-05-25 | Raskas Daniel | Director | A-Award | A | Common Stock | 4,020 | 0.00 | — | 14,285 | — | ↗ |
| 2021-05-25 | Jain Vivek | Director | A-Award | A | Common Stock | 4,020 | 0.00 | — | 13,220 | — | ↗ |
| 2021-05-25 | Huennekens R Scott | Director | A-Award | A | Common Stock | 5,455 | 0.00 | — | 27,425 | — | ↗ |
| 2021-05-25 | GALLAHUE KIERAN | Director | A-Award | A | Common Stock | 4,020 | 0.00 | — | 14,285 | — | ↗ |
| 2021-05-25 | Carruthers Wendy | Director | A-Award | A | Common Stock | 4,020 | 0.00 | — | 20,215 | — | ↗ |
| 2021-05-14 | Reis Mischa | Officer | F-InKind | D | Common Stock | 156 | 45.23 | 7.1K | 39,043 | — | ↗ |
Executive team
Top executives
EBIT / Employee
18.4K
Shares Outstanding
162.98M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Paul Keel President CEO, from May 1, 2024 | 1.10M | 281.5K | 10.70M | 10.70M | 1.09M | 368.6K | 24.24M | 88.30% | ↗ |
| 2 | 2024 | Amir Aghdaei, President CEO, until May 1, 2024 | 1.10M | — | 4.40M | 1.10M | 275.0K | 2.04M | 8.92M | 61.69% | ↗ |
| 3 | 2024 | Eric Hammes Chief Financial Officer, from August 1, 2024 | 575.0K | 1.02M | 1.20M | — | 168.9K | 238.9K | 3.20M | 37.47% | ↗ |
| 4 | 2024 | Mark Nance, SVP and General Counsel | 525.0K | — | 1.06M | 1.05M | 424.5K | 39.3K | 3.10M | 68.15% | ↗ |
| 5 | 2024 | Robert Befidi President, Diagnostics | 550.0K | — | 637.7K | 777.9K | 335.0K | 13.8K | 2.31M | 61.17% | ↗ |
| 6 | 2024 | Mischa Reis SVP, Strategy and Business Development | 475.0K | — | 725.3K | 640.6K | 299.3K | 74.6K | 2.21M | 61.67% | ↗ |
| 7 | 2024 | Stephen Keller Principal Financial Officer, until August 1, 2024 | 460.0K | — | 750.2K | 150.0K | — | 37.0K | 1.40M | 64.43% | ↗ |
| 8 | 2023 | Amir Aghdaei, President CEO | 1.10M | — | 4.16M | 1.04M | — | 759.1K | 7.06M | 73.66% | ↗ |
| 9 | 2023 | Amir Aghdaei, President CEO, until May 1, 2024 | 1.10M | — | 4.16M | 1.04M | — | 759.1K | 7.06M | 73.66% | ↗ |
| 10 | 2023 | Howard Yu, Senior Vice President and CFO, until September 22, 2023 | 550.0K | — | 1.18M | 393.9K | — | 113.5K | 2.24M | 70.36% | ↗ |
| 11 | 2023 | Eric Conley President, Orthodontics | 500.0K | — | 1.18M | 175.0K | 208.3K | 58.6K | 2.12M | 63.78% | ↗ |
| 12 | 2023 | Jean-Claude Kyrillos, SVP and President, Diagnostics and Digital Solutions, until June 30, 2023 | 525.0K | — | 637.8K | 212.6K | — | 473.8K | 1.85M | 45.99% | ↗ |
| 13 | 2023 | Patrik Eriksson, SVP and President of Nobel Biocare, until December 31, 2023 | 550.0K | — | 637.8K | 212.6K | 104.0K | 97.3K | 1.60M | 53.10% | ↗ |
| 14 | 2023 | Mark Nance, SVP and General Counsel | 525.0K | — | 712.5K | 237.7K | — | 68.0K | 1.54M | 61.57% | ↗ |
| 15 | 2023 | Stephen Keller Principal Financial Officer, effective September 22, 2023 | 410.0K | — | 125.1K | 125.1K | — | 43.7K | 703.9K | 35.54% | ↗ |
| 16 | 2023 | Stephen Keller Principal Financial Officer, until August 1, 2024 | 410.0K | — | 125.1K | 125.1K | — | 43.7K | 703.9K | 35.54% | ↗ |
| 17 | 2022 | Amir Aghdaei, President CEO, until May 1, 2024 | 1.10M | — | 4.08M | 1.02M | 725.3K | 1.60M | 8.52M | 59.84% | ↗ |
| 18 | 2022 | Amir Aghdaei, President CEO | 1.10M | — | 4.08M | 1.02M | 725.3K | 1.60M | 8.52M | 59.84% | ↗ |
| 19 | 2022 | Howard Yu, Senior Vice President and CFO, until September 22, 2023 | 525.0K | — | 1.13M | 375.1K | 217.5K | 99.6K | 2.34M | 64.05% | ↗ |
| 20 | 2022 | Howard Yu, Senior Vice President and CFO | 525.0K | — | 1.13M | 375.1K | 217.5K | 99.6K | 2.34M | 64.05% | ↗ |
| 21 | 2022 | Patrik Eriksson, SVP and President of Nobel Biocare | 550.0K | — | 637.6K | 212.6K | 203.1K | 81.5K | 1.68M | 50.46% | ↗ |
| 22 | 2022 | Patrik Eriksson, SVP and President of Nobel Biocare, until December 31, 2023 | 550.0K | — | 637.6K | 212.6K | 203.1K | 81.5K | 1.68M | 50.46% | ↗ |
| 23 | 2022 | Jean-Claude Kyrillos, SVP and President, Diagnostics and Digital Solutions | 525.0K | — | 637.6K | 212.6K | 229.7K | 59.3K | 1.66M | 51.09% | ↗ |
| 24 | 2022 | Jean-Claude Kyrillos, SVP and President, Diagnostics and Digital Solutions, until June 30, 2023 | 525.0K | — | 637.6K | 212.6K | 229.7K | 59.3K | 1.66M | 51.09% | ↗ |
| 25 | 2022 | Mark Nance, SVP and General Counsel | 525.0K | — | 675.3K | 225.1K | 174.0K | 54.6K | 1.65M | 54.44% | ↗ |
| 26 | 2021 | Amir Aghdaei, President CEO | 1.10M | — | 2.35M | 2.35M | 2.27M | 1.13M | 9.20M | 51.09% | ↗ |
| 27 | 2021 | Jean-Claude Kyrillos, SVP and President, Diagnostics and Digital Solutions | 475.0K | — | 425.1K | 2.43M | 497.5K | 32.6K | 3.86M | 73.93% | ↗ |
| 28 | 2021 | Jean-Claude Kyrillos, SVP and President, Diagnostics and Digital Solutions, until June 30, 2023 | 475.0K | — | 425.1K | 2.43M | 497.5K | 32.6K | 3.86M | 73.93% | ↗ |
| 29 | 2021 | Howard Yu, Senior Vice President and CFO, until September 22, 2023 | 525.0K | — | 500.0K | 500.1K | 639.8K | 62.8K | 2.23M | 44.89% | ↗ |
| 30 | 2021 | Howard Yu, Senior Vice President and CFO | 525.0K | — | 500.0K | 500.1K | 639.8K | 62.8K | 2.23M | 44.89% | ↗ |
| 31 | 2021 | Patrik Eriksson, SVP and President of Nobel Biocare, until December 31, 2023 | 550.0K | — | 425.1K | 425.0K | 532.3K | 86.6K | 2.02M | 42.11% | ↗ |
| 32 | 2021 | Patrik Eriksson, SVP and President of Nobel Biocare | 550.0K | — | 425.1K | 425.0K | 532.3K | 86.6K | 2.02M | 42.11% | ↗ |
| 33 | 2021 | Mark Nance, SVP and General Counsel | 525.0K | — | 350.2K | 350.1K | 519.8K | 50.5K | 1.80M | 39.00% | ↗ |
| 34 | 2020 | Amir Aghdaei, President CEO | 1.01M | — | 2.25M | 2.25M | 1.38M | 487.8K | 7.37M | 61.05% | ↗ |
| 35 | 2020 | Howard Yu, Senior Vice President and CFO | 495.0K | — | 500.1K | 500.0K | 374.1K | 64.5K | 1.93M | 51.72% | ↗ |
| 36 | 2020 | Patrik Eriksson, SVP and President of Nobel Biocare | 519.3K | — | 425.1K | 425.1K | 351.3K | 76.1K | 1.80M | 47.31% | ↗ |
| 37 | 2020 | Mark Nance, SVP and General Counsel | 495.7K | — | 300.1K | 300.0K | 315.0K | 17.9K | 1.43M | 42.00% | ↗ |
| 38 | 2020 | Jean-Claude Kyrillos, SVP and President of Kavo | 380.9K | — | 337.6K | 337.6K | 345.7K | 1.5K | 1.40M | 48.11% | ↗ |
| 39 | 2020 | Jean-Claude Kyrillos, SVP and President, Diagnostics and Digital Solutions | 380.9K | — | 337.6K | 337.6K | 345.7K | 1.5K | 1.40M | 48.11% | ↗ |
| 40 | 2019 | Amir Aghdaei, President CEO | 784.5K | — | 2.26M | 3.28M | 503.1K | 754.2K | 7.58M | 73.07% | ↗ |
| 41 | 2019 | Hans Geiselhöringer, Senior Vice President | 785.4K | — | 609.6K | 684.9K | 148.6K | 145.7K | 2.37M | 54.52% | ↗ |
| 42 | 2019 | Patrik Eriksson, Senior Vice President | 486.7K | — | 684.5K | 714.1K | 385.0K | 61.1K | 2.33M | 59.99% | ↗ |
| 43 | 2019 | Patrik Eriksson, SVP and President of Nobel Biocare | 486.7K | — | 684.5K | 714.1K | 385.0K | 61.1K | 2.33M | 59.99% | ↗ |
| 44 | 2019 | Curt Bludworth, Senior Vice President CHRO | 450.0K | 100.0K | 585.3K | 561.6K | 171.7K | 163.9K | 2.03M | 56.43% | ↗ |
| 45 | 2019 | Howard Yu, Senior Vice President and CFO | 407.1K | 85.0K | 657.8K | 690.5K | 146.4K | 16.8K | 2.00M | 67.29% | ↗ |
| 46 | 2018 | Amir Aghdaei, President CEO | 608.6K | — | 3.25M | 2.16M | 403.0K | 180.2K | 6.60M | 81.94% | ↗ |
| 47 | 2018 | Hans Geiselhöringer, Senior Vice President | 772.4K | — | 498.7K | 342.0K | 379.2K | 145.2K | 2.14M | 39.33% | ↗ |
| 48 | 2018 | Howard Yu, Senior Vice President and CFO | 330.6K | — | 217.3K | 154.8K | 159.6K | 1.06M | 1.92M | 19.36% | ↗ |
| 49 | 2018 | Curt Bludworth, Senior Vice President CHRO | 424.7K | 270.3K | 398.9K | 273.6K | — | 86.3K | 1.45M | 46.26% | ↗ |
| 50 | 2018 | Patrik Eriksson, Senior Vice President | 444.2K | — | 448.8K | 307.7K | 171.4K | 80.9K | 1.45M | 52.06% | ↗ |
| 51 | 2018 | Patrik Eriksson, SVP and President of Nobel Biocare | 444.2K | — | 448.8K | 307.7K | 171.4K | 80.9K | 1.45M | 52.06% | ↗ |
| 52 | 2017 | Amir Aghdaei, President CEO | 573.5K | — | 778.4K | 459.5K | 410.6K | 1.29M | 3.51M | 35.27% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Paul A. Keel | Chief Executive Officer & Director | 4M | male |
| Eric D. Hammes | Senior Vice President & Chief Financial Officer | 1M | male |
| Veronica Acurio | Senior Vice President & President of Orthodontics | 1M | female |
| Mark E. Nance | Senior Vice President, General Counsel & Secretary | 1M | male |
| Robert Befidi Jr. | Senior VP & President of Diagnostics | 1M | male |
| Mischa Reis | Senior Vice President of Strategy & Corporate Development | 848.9K | male |
| Jim Gustafson | Vice President of Investor Relations | 453.7K | male |
| Faez Kaabi | Vice President, Chief Accounting Officer & Corporate Controller | — | male |
| Paul Sumilas | Chief Compliance Officer | — | — |
| Suraj Satpathy | Chief Human Resources officer | — | male |
| Filippo Impieri | President of Consumables | — | male |
| Claudia Ortiz | Senior Vice President of Regulatory Affairs & Quality Assurance | — | female |
ESG Rating
ESG Score History MEDICAL - INSTRUMENTS & SUPPLIES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2024-06-06 | 2024-06-06 | Pete Sessions | TX17 | Spouse | Sale (Full) | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NVST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
